BioSpace News Archive

Propanc Biopharma, Inc. announced that a peer reviewed scientific article published by the Company and its research partners reached 3,000 reads on July 6, 2023, according to ResearchGate.

Simulations Plus, Inc. today announced the release of ADMET Predictor® 11, its flagship machine learning modeling platform.

Inogen, Inc. today announced that the company has entered into a definitive agreement to purchase Physio-Assist SAS, a privately-held company headquartered in France.

Model N, Inc., the leader in revenue optimization and compliance, plans to announce financial results for the third quarter of fiscal year 2023 after market close on Tuesday, August 8, 2023.

NovAccess Global Inc. today announced that its Chief Executive Officer Dr. Dwain K. Irvin will be participating in the National Brain Tumor Society’s (NBTS) fifth annual Glioblastoma Awareness Day on July 19, 2023 in support of the fight against one of the fastest growing and aggressive brain tumors.

Perrigo Company plc announced today that the U.S. Food and Drug Administration (FDA) approved Opill ® , a progestin-only daily oral contraceptive, for over-the-counter (OTC) use for all ages.

Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced the publication of data from its completed MB-105 European Phase 1 clinical trial assessing the safety and efficacy of Annamycin as a single agent for the treatment of adults with relapsed or refractory AML.

Quest Diagnostics today announced the launch of a novel prostate cancer biomarker test through its subspecialty pathology business, AmeriPath, in collaboration with Envision Sciences.

Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“ Sirona ”) provides the following update: Dear shareholders, We are pleased to provide an update on the progress we have made over the last months: Corporate Strategic Planning One of our communicated objectives in 2022 and the first half of 2023 was to conduct a thorough strategic review of the company.

Global health company The Cigna Group will release its second quarter 2023 financial results on Thursday, August 3, 2023, and will host a conference call the same day.